Cibus

Отрасль

Семена и генетика

Темы

ГМ-признаки и редактирование генома

Роль

Наука / R&D — “…ude Interoc, Fedearroz, and CIAT. <details><summary>Profile sources</summary> - - - - - — 2026-06-30 - - —…”

Почему это биоэкономика

Cibus создаёт с помощью редактирования генома признаки растений и лицензирует их семенным компаниям.

Пока не указана поставщиком в решениях с доказательствами.

• 2026-09 Последний статус: 28 сентября 2026 г. Cibus, Inc. заключила партнёрство с Crystal Crop Protection Limited по разработке признаков горчицы методом редактирования генов. ↗ ↗ ↗
• 2026-08-13 CBUS - Cibus, Inc. | News | OTC Markets
  Cibus is a technology company that uses its proprietary genome-editing platform to improve seed varieties with precise changes to the plant’s own genes (no foreign DNA), licenses those improvements back to seed companies for royalties, and reports a Q2 2026 …
• 2026-08-16 Cibus Q2 Earnings Call Highlights - The Lincolnian Online
  Cibus posted a Q2 2026 revenue of $1.0M (up from $0.9M) with six-month revenue of $2.7M (up 35%), narrowed Q2 net loss to $22.1M, and a leadership focus on near-term revenue, cost discipline, and balance-sheet strength under new CEO Craig Wichner. The company …
• 2026-08-13 Cibus Reports Second Quarter Financial Results and Provides Business Update | Markets Insider
  Cibus is a biology-based tech company that develops precise, non-GMO edits to crop genes, licenses the resulting improvements to seed companies for royalties, and aims to turn its platform into shareholder value through commercial partnerships and expanded …
• 2026-05-04 Cibus Announces Transfer of Gene-Edited Herbicide Tolerance
  Cibus reports a milestone in its strategy to commercialize gene-edited traits by transferring rice herbicide-tolerance materials to its partner Interoc for testing and production in Latin America, signaling progress toward its first commercial offerings in the …
• 2026-05-14 Cibus, Inc. (CBUS) 8-K Earnings Release - May 2026
  Cibus is a gene-editing technology company focused on developing and licensing plant traits to seed companies, with momentum in its Rice herbicide tolerance program aiming for a 2027 LATAM and 2029 U.S. launch, ongoing cost discipline, rising revenue, and a …
• 2026-08-13 Cibus Reports Second Quarter Financial Results and Provides Business Update | FinancialContent
  Cibus is a Nasdaq-listed biotechnology company that uses a proprietary platform to make precise, foreign-DNA-free edits to existing seed varieties, licenses the resulting improvements back to seed companies for royalties, and aims to scale through platform …

Партнёры и сделки 1

Похожие компании

Pairwise · Verinomics · Genective · Solis Agrosciences · MaxEditas · Meiogenix · Confluence Genetics · Thunder Seed Inc.